ABSTRACT
Fructose 1, 6 diphosphate (FDP), a metabolic intermediate, provides an alternative mechanism to circumvent the rate-limiting step in the Kreb's cycle. This agent has been observed to prevent the effects of ischemia on heart tissue and kidney function and the effects of endotoxic shock. It has been shown conclusively to minimize the adverse effects of ischemia-reperfusion injury in experimental pedicled skin flaps in animals. The present study was done to evaluate the effect of intra-arterial administration of FDP on salvage of ischemic microvascular transfer of gracilis muscle flaps in rats, with the premise that it might prolong the ischemia time of muscle flaps at room temperature, thus increasing chances of flap survival. Irrigation with FDP did not change the quantitative survival of the flaps, but there was qualitative improvement on histologic evaluation and DNA analysis. Decreased inflammatory damage and DNA fragmentation were seen at the 2.5-hr period. Histologic staining for mitochondrial oxygenation in gracilis muscle also showed increased uptake in the FDP-treated group vs. control at the 2.5-hr ischemia period. Further experiments with different modes of FDP administration should be carried out to identify more effective means of amelioration of flap ischemia.
KEYWORDS
Ischemia reperfusion injury - fructose diphosphate - microvascular transfer - gracilis muscle flaps in rats
REFERENCES
-
1
Didlake R, Kirchner K A, Lewin J, Bower J D, Markov A K.
Attenuation of ischemic renal injury with fructose 1, 6 diphosphate.
J Surg Research.
1989;
47
220-226
-
2
Markov A K, Oglethorpe N C, Blake T M, Lehman P H, Hellems H K.
Hemodynamic, elecctrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia.
Am Heart J.
1980;
100
639-646
-
3
Markov A K, Oglethorpe N, Young D B, Hellems H K.
Irreversible hemorrhagic shock: treatment and cardiac pathophysiology.
Circ Shock.
1981;
8
9-19
-
4
Sun J, Farias L A, Markov A K.
Fructose 1, 6 diphosphate prevents intestinal ischemic reperfusion injury and death in rats.
Gastroenterology.
1990;
98
117-126
-
5
Heckler F R, Markov A K, Jones E W.
Metabolic support of ischemic skin flaps with fructose 1, 6 diphosphate.
Surg Forum.
1984;
35
580-582
-
6
Yim K, Lineaweaver W C, Siko P P, Buncke H J.
Microvascular transfer of anterior and posterior gracilis muscles in rats.
Microsurgery.
1991;
12
262-267
-
7
Khouri R K.
Avoiding free flap failure.
Clin Plast Surg.
1992;
19
773-781
-
8
Russell R C, Roth A C, Kucan J O, Zook E G.
Reperfusion injury and oxygen free radicals. A review.
J Reconstr Microsurg.
1989;
5
79-85
-
9
Fernando B, Young V L, Logan S E.
Miniature implantable laser Doppler probe monitoring of free tissue transfer.
Ann Plast Surg.
1988;
20
434-438
-
10
Khouri R K, Cooley B C, Kenna D H, Edstrom L E.
Thrombosis of microvascular anastomoses in traumatized vessels: fibrin versus platelets.
Plast Reconstr Surg.
1990;
86
110-117
-
11
Greenberg B M, Masem M, May Jr J W.
Therapeutic value of intravenous heparin in microvascular surgery. An experimental vascular thrombosis study.
Plast Reconstr Surg.
1988;
82
463-470
-
12
Wolfort S, Angel M F, Knight K K, Amiss L R, Morgan R F.
The beneficial effect of dextran on anastomotic patency and flap survival in a strongly thrombogenic model.
J Reconstr Microsurg.
1992;
8
375-382
-
13
Weislander J B, Dougan P, Stjernquist U, Mecklenburg C V.
Effect of Dextran 70 and saline on thrombus formation following arteriotomy and intimectomy in small arteries.
Microsurgery.
1986;
7
168-174
-
14
Goldberg J A, Pederson W C, Barwick W J.
Salvage of free tissue transfers using thrombolytic agents.
J Reconstr Microsurg.
1989;
5
351-356
-
15
Markov A K.
Hemodynamics and metabolic effects of fructose 1, 6 diphosphate in ischemia and shock-Experimental and clinical observations.
Ann Emer Med.
1986;
15
1470-1477
-
16
Markov A K, Oglethorpe N, Grillis M, Neely W A, Hellems H K.
Therapeutic action of fructose 1, 6 diphosphate in traumatic shock.
World J Surg.
1983;
7
430-436
-
17
Markov A K, Turner M D, Oglethorpe N, Neely W A, Hellems H K.
Fructose 1, 6 diphosphate: an agent for treatment of experimental endotoxin shock.
Surgery.
1981;
90
482-488
-
18
Markov A K, Street D, Terry J T, Didlake R D, Hellems H K.
Tissue and organ protection with fructose diphosphate in hemorrhagic shock.
Microvasc Res.
1983;
25
275-283
-
19
Markov A K, Finch C D, Hellems H K.
Prevention of superoxide generation and inhibition of oxygen burst in human and canine neutrophils with fructose 1,6 dephosphate (FDP).
Microcirculation.
1987;
1
691-698
-
20
Knight K R, Messina A, Hurley J V, Zhang B, Morrison W A, Stewart A G.
Muscle cells become necrotic rather than apoptotic during reperfusion of ischaemic skeletal muscle.
Int J Exp Path.
1999;
80
169-175
-
21
Heckler F R, Markov A K, White T Z, Jones E W.
Effect of fructose 1, 6 diphosphate on canine hind limbs subjected to tourniquet ischemia.
J Hand Surg.
1983;
8
622-623
-
22
Hardin C H, Roberts T M.
Metabolism of exogenously applied fructose 1, 6- diphosphate in hypoxic vascular smooth muscle.
Am J Physiol.
1994;
267
H2325-H2332
-
23
Manani G, Galzigna L, Costa G et al..
Experimental effects on rabbit ileum and biochemical action of fructose 1,6 diphosphate.
Agressologie.
1977;
18
201-208
Sheila G LindleyM.D.
Department of Orthopedic Surgery, University of Mississippi Medical Center
2500 N. State street, Jackson, MS 39216
